EcoR1 Capital’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-426,683
| Closed | -$2.63M | – | 48 |
|
|
2024
Q4 | $2.63M | Buy |
426,683
+372,849
| +693% | +$2.3M | 0.1% | 47 |
|
|
2024
Q3 | $290K | Buy |
+53,834
| New | +$290K | 0.01% | 60 |
|
|
2023
Q1 | – | Sell |
-884,903
| Closed | -$9.08M | – | 61 |
|
|
2022
Q4 | $9.08M | Sell |
884,903
-1,634,365
| -65% | -$16.8M | 0.28% | 42 |
|
|
2022
Q3 | $42.1M | Sell |
2,519,268
-114,910
| -4% | -$1.92M | 1.24% | 18 |
|
|
2022
Q2 | $36.9M | Buy |
2,634,178
+262,733
| +11% | +$3.68M | 1.27% | 24 |
|
|
2022
Q1 | $38.3M | Buy |
2,371,445
+218,448
| +10% | +$3.53M | 1.2% | 23 |
|
|
2021
Q4 | $46.1M | Buy |
2,152,997
+289,899
| +16% | +$6.21M | 1.47% | 21 |
|
|
2021
Q3 | $27.4M | Buy |
1,863,098
+603,079
| +48% | +$8.86M | 0.95% | 19 |
|
|
2021
Q2 | $25.1M | Buy |
1,260,019
+122,079
| +11% | +$2.43M | 0.94% | 23 |
|
|
2021
Q1 | $34M | Buy |
+1,137,940
| New | +$34M | 1.51% | 19 |
|